{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:19:03Z","timestamp":1769149143026,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.semarthrit.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T16:59:17Z","timestamp":1618765157000},"page":"547-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis"],"prefix":"10.1016","volume":"51","author":[{"given":"Andreea C","family":"Damian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Colaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Rohekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafna D","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihi","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.04.008_bib0001","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0002","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0004","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0005","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.CIR.0000078468.11849.66","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0007","article-title":"Venous thrombosis","volume":"1","author":"Wolberg","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-04-0266","article-title":"The relationship between inflammation and venous thrombosis. A systematic review of clinical studies","volume":"94","author":"Fox","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0009","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1160\/TH09-04-0274","article-title":"C-reactive protein and venous thromboembolism: a prospective investigation in the ARIC cohort","volume":"102","author":"Folsom","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0010","first-page":"1120","article-title":"Activation of coagulation after administration of tumor necrosis factor to normal sujects","volume":"323","author":"Van der Poll","year":"1993","journal-title":"New English J Med"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1160\/TH08-08-0551","article-title":"Risk of venous thromboembolism with rheumatoid arthritis","volume":"101","author":"Matta","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0012","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2013-204767","article-title":"Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system","volume":"73","author":"van den Oever","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0013","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/annrheumdis-2013-203380","article-title":"Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study","volume":"73","author":"Chung","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0014","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","article-title":"A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases","volume":"16","author":"Lee","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10067-014-2492-7","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"33","author":"Ungprasert","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0016","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/acr.22039","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0017","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/annrheumdis-2012-201669","article-title":"The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study","volume":"72","author":"Choi","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0018","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/2012.jama.11741","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization","volume":"308","author":"Holmqvist","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0019","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2015.05.008","article-title":"The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: a general population-based study","volume":"45","author":"Avi\u00f1a-Zubieta","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3899\/jrheum.150506","article-title":"Venous and arterial thrombotic events in systemic lupus erythematosus","volume":"43","author":"Hinojosa-Azaola","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0021","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/0961203317716306","article-title":"Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: a Danish nationwide cohort study","volume":"26","author":"Ahlehoff","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0022","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/qjmed\/hcu073","article-title":"Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis","volume":"107","author":"Ungprasert","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0023","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1160\/TH17-01-0039","article-title":"Increased risks of venous thromboembolism in patients with psoriasis: a nationwide cohort study","volume":"117","author":"Chung","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-1","article-title":"Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study","volume":"9","author":"Ramagopalan","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0025","doi-asserted-by":"crossref","first-page":"e18125","DOI":"10.1371\/journal.pone.0018125","article-title":"Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study","volume":"6","author":"Ahlehoff","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0026","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1093\/eurheartj\/ehx145","article-title":"Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study","volume":"39","author":"Ogdie","year":"2018","journal-title":"Eur Hear J"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/1744666X.2019.1699058","article-title":"Unmet needs in the management of cardiovascular risk in inflammatory joint diseases","volume":"16","author":"Casta\u00f1eda","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0028","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40264-017-0622-2","article-title":"Analysis of spontaneous postmarket case reports submitted to the FDA regarding thromboembolic adverse events and JAK inhibitors","volume":"41","author":"Verden","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0029","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2019-216761","article-title":"Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data","volume":"79","author":"Mease","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0030","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0031","first-page":"127","article-title":"Psoriatic arthritis (PSA)\u2013an analysis of 220 patients","volume":"62","author":"Gladman","year":"1987","journal-title":"Q J Med"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0032","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2012.04646.x","article-title":"Psoriasis is associated with a greater risk of incident venous thromboembolism: the Iowa Women's Health Study","volume":"10","author":"Lutsey","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0033","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/rth2.12113","article-title":"Immigration, region of origin, and the epidemiology of venous thromboembolism: a population-based study","volume":"2","author":"Lazo-Langner","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0034","doi-asserted-by":"crossref","first-page":"879.e19","DOI":"10.1016\/j.amjmed.2016.01.041","article-title":"Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study","volume":"129","author":"Alotaibi","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0035","doi-asserted-by":"crossref","first-page":"832.e13","DOI":"10.1016\/j.amjmed.2013.02.024","article-title":"Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort","volume":"126","author":"Tagalakis","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0036","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0037","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1160\/TH17-01-0039","article-title":"Increased risks of venous thromboembolism in patients with psoriasis. A nationwide cohort study","volume":"117","author":"Chung","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2015.10.019","article-title":"Diabetes mellitus and venous thromboembolism: a systematic review and meta-analysis","volume":"111","author":"Bell","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0039","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3899\/jrheum.160861","article-title":"The risk of developing diabetes mellitus in patients with psoriatic arthritis: a cohort study","volume":"44","author":"Eder","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0041","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00281-017-0666-5","article-title":"Hemostasis, endothelial stress, inflammation, and the metabolic syndrome","volume":"40","author":"Grandl","year":"2018","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0042","article-title":"Association of inflammatory skin diseases with venous thromboembolism in US adults","author":"Shaheen","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0043","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2176\/nmc.53.467","article-title":"Risk assessment for venous thromboembolism in patients with neuroepithelial tumors: pretreatment score to identify high risk patients","volume":"53","author":"Kawaguchi","year":"2013","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0044","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.wneu.2016.01.033","article-title":"Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis","volume":"89","author":"Lieber","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.semarthrit.2021.04.008_bib0045","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:05:54Z","timestamp":1758733554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0049017221000627"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.008","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}